Cetera Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Cetera Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.38K	Hold	21	–	–	0.01%	301
2025 Q4	$9.52K	Hold	21	–	–	0.01%	301
2025 Q3	$8.22K	Hold	21	–	–	﹤0.01%	307
2025 Q2	$9.35K	Hold	21	–	–	0.01%	298
2025 Q1	$10.2K	Hold	21	–	–	0.01%	290
2024 Q4	$8.46K	Hold	21	–	–	0.01%	308
2024 Q3	$9.77K	Hold	21	–	–	0.01%	303
2024 Q2	$9.84K	Hold	21	–	–	0.01%	294
2024 Q1	$8.78K	Hold	21	–	–	0.01%	309
2023 Q4	$8.54K	Buy	+21	New	+$7.76K	0.01%	306

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cetera Trust Company's VRTX Position: Q1 2026 in Review

Cetera Trust Company held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 21 shares worth $9.38K. The position accounts for 0.01% of the portfolio, ranked #301.

Cetera Trust Company first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.2K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Cetera Trust Company held 21 shares of Vertex Pharmaceuticals worth $9.38K as of Q1 2026.
Cetera Trust Company left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
Vertex Pharmaceuticals made up 0.01% of Cetera Trust Company's portfolio in Q1 2026, its #301 holding.
Cetera Trust Company first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
Cetera Trust Company's Vertex Pharmaceuticals position peaked at $10.2K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.